{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:27:34Z","timestamp":1789914454453,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000664","name":"NIHR Health Technology Assessment Programme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejca.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T04:57:16Z","timestamp":1298091436000},"page":"864-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial"],"prefix":"10.1016","volume":"47","author":[{"given":"Henry C.","family":"Kitchener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gilham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Albrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2011.01.008_b0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer screening epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ejca.2011.01.008_b0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"issue":"9601","key":"10.1016\/j.ejca.2011.01.008_b0015","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2011.01.008_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2011.01.008_b0025","doi-asserted-by":"crossref","unstructured":"Kitchener HC, Almonte M, Dowie R et al., ARTISTIC: a randomised trial of HPV testing in primary cervical screening. Health Technol Assess 2009; 13(51).","DOI":"10.3310\/hta13510"},{"issue":"21","key":"10.1016\/j.ejca.2011.01.008_b0030","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2011.01.008_b0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2011.01.008_b0040","unstructured":"NHS Cervical Screening Programme, Colposcopy and Programme Management \u2013 Guidelines for the NHS Cervical Screening Programme, NHS Cancer Screening Programmes: Sheffield, 2004."},{"issue":"9686","key":"10.1016\/j.ejca.2011.01.008_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2011.01.008_b0050","unstructured":"Greenwood M, The natural duration of cancer. Reports on Public Health and Medical Subjects. Her Majesty\u2019s Stationery Office: London; 1926. p. 1\u201326."},{"key":"10.1016\/j.ejca.2011.01.008_b0055","unstructured":"STATA 11, StataCorp: College Station, TX; 2009."},{"key":"10.1016\/j.ejca.2011.01.008_b0060","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology, human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejca.2011.01.008_b0065","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2011.01.008_b0070","doi-asserted-by":"crossref","unstructured":"Franceschi S, Denny L, Irwin KL et al., Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011; [Epub ahead of print].","DOI":"10.1002\/ijc.25915"},{"issue":"5","key":"10.1016\/j.ejca.2011.01.008_b0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6605528","article-title":"Predicted impact of vaccination against human papillomavirus 16\/18 on cancer incidence and cervical abnormalities in women aged 20\u201329 in the UK","volume":"102","author":"Cuzick","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2011.01.008_b0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6603501","article-title":"Estimating the long-term impact of a prophylactic human papillomavirus 16\/18 vaccine on the burden of cervical cancer in the UK","volume":"96","author":"Kohli","year":"2007","journal-title":"Br J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:17:32Z","timestamp":1760732252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804911000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0959804911000323"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.01.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2011.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}